Rare
lephants
Screener
Toggle theme
Altimmune, Inc.
ALT
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
Book Per Share
Compare
←
5Y
10Y
MAX
→
Book Per Share
Chart
Table
Book Per Share
Cash Per Share
Fiscal Year
Book Per Share
Cash Per Share
FY2023
$3.65
$2.54
FY2024
$1.74
$0.52
FY2025
$2.55
$0.50
Download CSV
